Nuclear & Radiological Security Protocol for “Smart Gas” Facilities, 2026

National Security Framework of Antarctica (NSF-A)

Article — Effective 1 January 2027

Important safety note: Weaponisation of gases or agents intended to harm people is strictly prohibited is a strict, harm-minimising security and compliance protocol that forbids weaponisation and confines any “Smart Gas” activity to tightly licensed, auditable pharmaceutical and fundamental science use only.

Article 1 — Purpose & Scope

1.1 This Protocol establishes nuclear/radiological, chemical, cyber-physical, and governance controls for facilities investigating “Smart Gas”—a speculative, high-hazard gaseous medium associated with Space-Time current research—solely for lawful pharmaceutical and fundamental research.

1.2 It prohibits weaponisation (including so-called “psychochemical warfare”) and sets the licensing, monitoring, audit, and incident-response duties under the Domestic Compliance Framework (DCF).

Article 2 — Prohibition on Weaponisation

2.1 Absolute ban. Any development, production, stockpiling, transfer, testing, or operational planning of agents intended to degrade cognition, coerce behaviour, or cause harm is illegal.

2.2 Scope. Prohibition covers formulations, precursors, dissemination systems, and data packages enabling operational misuse.

2.3 Penalties. Licence revocation, asset seizure, officer blacklisting, and criminal referral under national-security offences.

Article 3 — Definitions

3.1 Smart Gas (SG). Any gaseous mixture or field-mediated phenomenon arising from Space-Time current experiments or analogous processes that exhibits biologically active or sensor-responsive behaviours.

3.2 SG Facility. A site conducting SG generation, capture, conditioning, storage, measurement, or pharmacological screening.

3.3 SG-Pharma Use. Research limited to therapeutic hypothesis testing, with approved protocols, non-lethal dose modelling, and medical ethics oversight.

3.4 DURC. Dual-Use Research of Concern—work reasonably anticipated to be misapplied to harm populations or security.

Article 4 — Governance & Licensing

4.1 Required licences:

1. Nuclear/Radiological Facility Licence (NRFL) — where SG generation couples to nuclear or radiological apparatus.
2. Controlled Chemical Research Licence (CCRL) — for any biologically active or hazardous gases.
3. Digital Infrastructure Licence (DIL) — for IT/OT platforms.
4. Commercial Science Licence (CSL) — negotiations: L3 baseline; Bachelor-level for deals > USD 75,000; Advanced + risk review for > USD 3,000,000.
5. 4.2 Oversight bodies:
6. Institutional DURC & Ethics Board (IDEB) — mandatory approval and continuous review.
7. Radiation Safety Committee (RSC) — shielding, ALARA, dosimetry.
8. Medical Oversight Officer (MOO) — pharmacovigilance and human/animal protections (no human exposure unless separately authorised).
9. 4.3 Registries. All licences, approvals, SOPs, and experiments are anchored in Certified Digital Democracy (CDD).

Article 5 — Physical Containment & Engineering Controls

5.1 Zoning.

1. Zone R (Radiological): Shielded vaults, interlocks, negative pressure, SG-rated exhaust scrubbing.
2. Zone C (Chemical): BSL-equivalent containment for gases; redundant gas cabinets; auto-shutoff.
3. Zone O (Operations Spine): Utilities, decontamination, waste export; no process chemistry.
4. 5.2 Plant design. Modular, fail-safe (air-fail closed), double-walled lines, burst disks to safe stacks, continuous monitoring (PPM/PPB with calibration schedules).
5. 5.3 Ventilation & scrubbing. Inline HEPA/chemical media; monitored emissions; zero uncontrolled venting.
6. 5.4 Shielding & criticality (if applicable). Verified shielding calculations; interlocked access; real-time dosimetry with badge gates.

Article 6 — Material Control & Accountability (MC&A)

6.1 Inventory. All SG precursors, catalysts, sorbents, and cylinders are itemised with daily reconciliations.

6.2 Key controls. Dual-person access to vaults; tamper-evident seals; automated weigh-back at issue/return.

6.3 Samples & data. Aliquoting under camera; QR-hashed labels tied to CDD; no off-ledger stores.

Article 7 — Digital Trust, OT Security & Telemetry

7.1 Device trust. All PLCs, mass specs, FTIR/GC-MS, environmental sensors and HMI stations are MPSL-attested and operate on the Civilian DMZ.

7.2 Segmentation. One-way data diodes from OT to data lake; signed updates; SBOMs registered.

7.3 Telemetry. Continuous logging of pressures, flows, concentrations, radiation fields, alarms; immutable write-ahead logs to CDD.

7.4 Privacy. Research data minimised; any human-subject data requires explicit IDEB approval and is Restricted Tier.

Article 8 — Personnel, Competence & Vetting

8.1 Roles. Radiation Protection Supervisor, Gas Safety Engineer, OT Security Lead, Pharmacology PI, and Compliance Officer.

8.2 Vetting. Identity, sanctions, criminal, and fitness checks proportionate to access level; no private investigators (SPA-only investigations).

8.3 Training. Initial certs + ≥ 28 hours/month CPD/CPE; annual emergency drills; red-team tabletop for DURC scenarios.

Article 9 — Experimental Ethics & DURC Gatekeeping

9.1 Pre-registration. All protocols pre-registered in CDD with hypotheses, dose ceilings, antidote plans, and termination criteria.

9.2 Red-lines. No dissemination studies, crowd-exposure modelling, or delivery vector optimisation.

9.3 Publication discipline. Public communications are licensed under MIM; sensitive parameters or yields are Restricted Tier with de-risked summaries.

Article 10 — Emergency Preparedness & Response

10.1 Triggers. Concentration exceedance, detector anomaly, ventilation failure, unexpected radiological reading, medical symptom onset.

10.2 Golden hour.

a) Isolate & inert (close valves, purge to scrubbers).

b) Protect life (PPE/SCBA, muster, medical triage).

c) Preserve evidence (freeze logs, video, samples).

d) Notify SPA & Regulators within 15 minutes; case registration in CDD.

10.3 Medical. On-site antidotes/oxygen where indicated; hospital interface kits with anonymised exposure cards.

10.4 Re-entry. Gas-freeing certificate, instrumented clearance, and IDEB/RSC sign-off.

Article 11 — Waste, Emissions & Decommissioning

11.1 Waste. Classified as radiological, hazardous chemical, or mixed; sealed, weighed, tracked; export via licensed routes only.

11.2 Emissions. Continuous emissions monitoring; caps per permit; automatic shutdown on breach.

11.3 Decom. As-found EB survey → remove plant → verify clean closure; long-term records retained ≥ 20 years.

Article 12 — Information Control (MIM) & Public Safety

12.1 Alerts/Notices. Only MIM-licensed channels for advisories and updates; contraband publications are offences.

12.2 Risk communication. Plain guidance templates; no speculative claims; corrections posted within 60 minutes of new facts.

Article 13 — Antitrust & Antiterrorism Safeguards

13.1 Antitrust. Misleading scientific/medical claims, off-ledger experiments, or device-policy bypass → Scope Restriction Orders and takedowns via MIM.

13.2 Antiterrorism. Any indication of intent to coerce/harm the public triggers Protective Disruption Orders, seizure of materials, account revocation, and SPA lead with no-notice actions.

13.3 Private/foreign investigations. Prohibited; only SPA may investigate.

Article 14 — Audits, KPIs & Compliance

14.1 Audits. Assurance-tiered (AL1–AL4) covering radiological safety, gas handling, OT security, DURC, and records; unannounced inspections permitted.

14.2 KPIs (illustrative). Alarm response ≤ 3 min; zero uncontrolled releases; 100% inventory reconciliation; audit pass ≥ 95%; telemetry completeness ≥ 99.5%.

14.3 Non-conformities. CAPA within defined SLA; repeated major findings → suspension.

Article 15 — Sanctions & Appeals

15.1 Sanctions. Fines, suspension/revocation of NRFL/CCRL/DIL/CSL, asset seizure, criminal referral for endangerment or weaponisation attempts.

15.2 Appeals. File within 15 working days; emergency orders are not stayed.

Article 16 — Transitional & Final Provisions

16.1 Transition. Existing labs must file DURC matrices and complete DMZ/MPSL/CDD integration within 180 days; emissions monitoring live within 90 days.

16.2 Supremacy. Conflicting guidance is superseded on the effective date.

Contacts

1. Licensing (NRFL/CCRL/DIL/CSL): licensing@nsf-antarctica.org
2. Radiation & Gas Safety: safety-nrg@nsf-antarctica.org
3. DURC & Ethics Board: ideb@nsf-antarctica.org
4. SPA (Emergencies 24/7): spa-ops@nsf-antarctica.org
5. Ombuds & Whistleblowing: ombuds-research@nsf-antarctica.org

This protocol enables tightly governed therapeutic and fundamental research while drawing a bright, non-negotiable line: no weaponisation—ever.